HitchAI
Health & Human Services · President's Budget PB2027

Intramural Research

Health & Human Services·Intramural Research·CJ p. 11
FY2027 Request
$25.5M
Parsed · CJ — verify
FY2026 enacted $26.7M
Parsed · verify

This figure was parsed from Health & Human Services's FY2027 Congressional Justification, not from a standard budget exhibit. It is approximate and it is not summable with other lines. It is published so you can check it: the citation below names the exact page it was read off. Where a dollar figure matters, verify it there before using it.

The FY2027 President's Budget requests $25.5M for Intramural Research, within Health & Human Services's Intramural Research account. That is down 4.4% on the FY2026 figure of $26.7M, which is the enacted appropriation.

Funding

FY2025–FY2027

Fiscal yearBasisAmount
FY2025enacted$27.0M
FY2026enacted$26.7M
FY2027request$25.5M

Bases are separate columns and are never summed into one figure.

Authoritative context

Health & Human Services discretionary budget authority

FY2027 request$91.60B
FY2026$131.10B
Change▼ 30%

From the OMB Public Budget Database — clean, summable, and the figure to cite for an agency total. It is the whole of Health & Human Services's discretionary request, not a total of the parsed lines above, and this page never adds the two together.

In the agency's own words

What this funds

History of Budget Authority and FTEs: National Institute of Biomedical Imaging and Bioengineering * Includes FTEs whose payroll obligations are supported by the NIH Common Fund. ** For FY 2026 Enacted, funding levels are displayed for statutory and report-directed PPAs. Amounts with an asterisk represent other PPAs as levels National Institute of Biomedical Imaging and Bioengineering Program funds are allocated as follows: Competitive Grants/Cooperative Agreements; Contracts; Overall Budget Policy: The FY 2027 President's Budget request for the National Institute of or 7.3 percent compared with the FY 2026 Enacted level. NIBIB supports biomedical imaging and bioengineering technologies through key investments in research and training across its extramural and intramural research programs. Technology enables medical discoveries that benefit public health and the biomedical research enterprise and provides innovative solutions to pressing health care challenges. NIBIB investments span from basic research to commercialization of new technologies to improve health. Division of Applied Science and Technology (DAST) DAST supports researchers and clinicians who are working to develop new tools and methods to better diagnose and treat disease as well as gain deeper insight into biological and disease processes. These efforts aim to improve human health by producing more innovative, cost- effective and accessible technologies. DAST highlights of research in this area include: Developing flexible imaging coils to improve image quality for pediatric patients: In magnetic resonance imaging (MRI), most existing hardware has been designed for adults. It is rigid, heavy, restrictive, and uncomfortable for many patients, and particularly for pediatric patients. Often, anesthesia is needed for pediatric patients currently in need of MRI imaging. In this study, researchers developed more flexible imaging coils that are optimized for smaller structures and can wrap around the abdomen of pediatric patients, similar to a blanket. These coils produced the same or higher quality images in less time.1 This technological advancement could improve MRI imaging for pediatric patients, reduce the need for sedation and long hospital (or spinal taps), which can be used to diagnose disease or deliver medicine, frequently require physicians to use their hands to feel a gap between two lumbar bones and then insert a needle. Clinicians may need to make several attempts, which can be painful for the patient and can lead to sample contamination. With the goal of improving needle placement, two forms of augmented reality (a tablet that uses its camera for tracking or a head-mounted display worn by a user that uses optics for tracking) were evaluated. The system integrated three components: a cell phone- sized ultrasound imager for visualization of the spine, algorithms that help to estimate the location of the lumbar bones, and an augmented reality display that superimposes the target location onto the spine to guide needle insertion. Using these tools, the needle could accurately hit the intended target in simulated experiments.2 Future work will focus on further development of this system for clinical evaluation and commercialization. Budget Policy: The FY 2027 President's Budget request for the DAST is $162.4 million. Division of Discovery Science and Technology (DDST) DDST builds broadly applicable technologies like prosthetics or wearable devices that interface directly with human physiology and tune biological processes to prevent, diagnose, and treat disease. The division also works to support the translation of these technologies from the lab to the clinic, emphasizing the development of scalable, impactful technologies. Key investment areas for NIBIB include bionics, synthetic biology, robotics, biomaterials, and new approach methodologies (NAMs). Highlights of research supported in this area include: Monitoring chronic wounds with a "smart bandage": Some individuals do not heal

Extracted from NIH - National Institute of Biomedical Imaging and Bioengineering, p. 11. Verbatim; nothing here is paraphrased.

Ask Hitch

Ask this budget line

Answers come from the figures on this page and nothing else. These dollars are parsed from Health & Human Services's Congressional Justification and are approximate — confirm anything that matters against the cited page.

H
Questions this page can answer
What does Intramural Research fund?How has the funding changed year over year?How does this sit inside Health & Human Services's discretionary budget?Where can I verify this figure?

This page carries the budget justification only. Contract obligations live at hitchintel.com/vendors; open solicitations at hitchintel.com/opportunities.